AddedRisk Factors
We may use generative artificial intelligence and/or machine learning (collectively, “AI”) tools in our operations. If our peers use AI tools to optimize operations and we fail to utilize AI tools in a comparable manner, we may be competitively disadvantaged. However, while AI tools may facilitate optimization and operational efficiencies, they also have the potential for inaccuracy, bias, infringement or misappropriation of intellectual property, and risks related to data privacy and cybersecurity. The use of AI tools may introduce errors or inadequacies that are not easily detectable, including deficiencies, inaccuracies or biases in the data used for AI training, or in the content, analyses or recommendations generated by AI applications. The results of such errors or inadequacies may adversely affect our business, financial condition and results of operations. The legal requirements relating to AI continue to evolve and remain uncertain, including how legal developments could impact our business and ability to enforce our proprietary rights or protect against infringement of those rights. Cybersecurity threat actors may utilize AI tools to automate and enhance cybersecurity attacks against us. We utilize software and platforms designed to detect such cybersecurity threats, including AI-based tools, but these threats could become more sophisticated and harder to detect, contain and mitigate, which may pose significant risks to our data security and systems. Such cybersecurity attacks, if successful, could lead to data breaches, loss of confidential or sensitive information, and financial or reputational harm. The integration of AI tools in the healthcare industry may present significant opportunities and risks for our operators and managers, similar to those risks described above.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedRisk Factors
Our vendors may use AI tools in their products or services without our knowledge, and the providers of these tools may not meet the evolving regulatory or industry standards for privacy and data protection. Consequently, this may inhibit our or our vendors’ ability to uphold an appropriate level of service and data privacy. If we, our vendors, or other third parties with which we conduct business experience an actual or perceived breach of privacy or security incident due to the use of AI, we may be adversely impacted, lose valuable intellectual property or confidential information and incur harm to our reputation and the public perception of the effectiveness of our security measures. In addition, investors, analysts and other market participants may use AI tools to process, summarize or interpret our financial information or other data about us. The use of AI tools in financial and market analysis may introduce risks similar to those described above, including an inaccurate interpretation of our financial or operational performance or market trends or conditions, which in turn could result in inaccurate conclusions or investment recommendations.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedRisk Factors
Rents we receive from a TRS in a RIDEA structure are treated as qualifying rents from real property for REIT tax purposes only if (i) they are paid pursuant to a lease of a “qualified healthcare property” and (ii) the operator qualifies as an “eligible independent contractor,” as each term is defined in the Code. If either of these requirements is not satisfied, then the rents we receive from the TRS will not be qualifying rents and we may not satisfy the REIT gross income requirements.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedRisk Factors
If we lose our REIT status, we will face serious tax consequences that will substantially reduce the funds available to make payments of principal and interest on the debt securities we issue and to make distributions to stockholders. If we fail to qualify as a REIT:
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RemovedRisk Factors
In addition, the market for qualified personnel is highly competitive. Our operators have experienced and may continue to experience difficulties in attracting and retaining such personnel, in particular due to labor constraints and, in some cases, wage increases, which have been elevated since the beginning of the COVID-19 pandemic and may remain elevated. These labor constraints may also be adversely impacted by immigration restrictions and changes to immigration enforcement policy to the extent they impact our operators’ workforces and by minimum staffing requirements that have been established in certain states and proposed at the federal level. Increases in labor costs could affect our operators’ ability to meet their obligations to us.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedRisk Factors
Inflation, both real or anticipated, as well as any responsive governmental policies, has and may continue to adversely affect the economy and the costs of labor, goods and services to our operators or borrowers. Inflation may also be adversely impacted by the imposition of additional tariffs by the U.S. federal government, which have been proposed and the impacts of which remain uncertain. Our long-term leases and loans typically contain provisions such as rent and interest escalators that are designed to mitigate the adverse impact of inflation on our results of operations. However, these provisions may have limited effectiveness at mitigating the risk of high levels of inflation due to contractual limits on escalation that exist in substantially all of our escalation provisions. Our leases are triple-net and typically require the operator to pay all property operating expenses, and therefore, increases in property-level expenses at our leased properties generally do not directly affect us. However, increased operating costs resulting from inflation have had, and may continue to have, an adverse impact on our operators and borrowers if increases in their operating expenses exceed increases in their reimbursements, which has and may continue to adversely affect our operators’ or borrowers’ ability to pay rent or other obligations owed to us.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedRisk Factors
An increase in our operators’ expenses and a failure of their reimbursements to increase at least with inflation could adversely impact our operators’ and our financial condition and our results of operations.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedRisk Factors
The Internal Revenue Service, the U.S. Treasury Department and Congress frequently review U.S. federal income tax legislation, regulations and other guidance. We cannot predict whether, when or to what extent new U.S. federal tax laws, regulations, interpretations or rulings will be adopted. Any legislative action may prospectively or retroactively modify our tax treatment and, therefore, may adversely affect taxation of us, our properties, or our shareholders.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RewordedRisk Factors
Failure We are exposed to maintain effective internal control over financial reporting operational risks with respect to our properties managed in RIDEA structures that could have a material adverse effect on our business, results of operations, operations and financial condition and stock price. condition.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedRisk Factors
While we are unable to predict the scope of future federal, state and local regulations and legislation, including the Medicare and Medicaid statutes and regulations, we believe that long-term care providers will continue to be the focus of governmental investigations, particularly in the area of Medicare/Medicaid false claims and in the use of COVID-19 related funds, including the Employee Retention Credit, and compliance with infection control and quality standards.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our financial position could be weakened and our ability to make distributions and fulfill our obligations with respect to our indebtedness could be limited if our operators, operators (which reference, throughout this section, includes our TRS entities when we use a RIDEA structure and our managers, unless otherwise noted), or a portion thereof, become unable to meet their obligations to us or fail to renew or extend their relationship with us as their lease terms expire or their mortgages mature, or if we become unable to lease or re-lease our facilities or make mortgage loans on economically favorable terms.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedRisk Factors
These The ultimate timing or effect of these changes cannot be predicted, and they may have a dramatic effect on our operators’ costs of doing business and on the amount level of reimbursement by both government and other third-party payors. payor reimbursements.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, requirements applicable to our operators are subject to frequent and substantial changes (sometimes applied retroactively) retroactive) resulting from new legislation, adoption of rules and regulations, changes in presidential administrations, and administrative and judicial interpretations of existing law, legal interpretations, and any changes in the regulatory framework could have a material adverse effect on our tenants, operators, guarantors operators and managers. obligors.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedRisk Factors
These risks include, but are not limited to, any international currency gain recognized with respect to changes in exchange rates may not qualify under the income tests that we must satisfy annually in order to qualify and maintain our status as a REIT; fluctuations in the exchange rates between USD and USD, the British Pound Sterling (“GBP”), (“GBP”) and the Canadian dollar, or other foreign currencies in which we may transact in the future, which we may be unable to protect against through hedging; changes in foreign political, regulatory, and economic conditions, including increases in energy prices, such as those experienced in the U.K. resulting in part from the conflict in Ukraine and sanctions imposed on Russia; challenges in managing international operations and enforcing obligations in other countries; challenges of complying with a variety of foreign laws and regulations, including those relating to real estate, healthcare operations, environmental, climate impacts, taxes, employment and legal proceedings; proceedings, and the level of sanctions for noncompliance under foreign laws; financial risks to our operators, including differences in expenses and government reimbursement practices, as well as funding challenges in the public sector; differences in lending practices and the willingness of domestic or foreign lenders to provide financing; regional or country-specific business cycles and economic instability; and changes in applicable laws and regulations in the U.S. that affect foreign operations.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our operators are subject to numerous federal, national, state and local laws and regulations in the U.S. and, for certain operators, in the U.K., U.S., U.K. or Canada, including those described in Item 1 – Business – Government Regulation and Reimbursement.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our operators may encounter increased competition in the future future, including due to changing technologies, political and regulatory conditions, and cultural trends, that could limit their ability to attract residents or expand their businesses and therefore affect their ability to pay their lease or mortgage payments and meet their obligations to us.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedRisk Factors
Developing and implementing an interest rate risk a strategy to hedge these risks is complex and no strategy can completely insulate us from risks associated with interest rate fluctuations in these rates, and there can be no assurance that our hedging activities will be effective.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, at December 31, 2024, 2025, one operator represented greater than 10% of our investments, and the three states geographic locations in which we had our highest concentration of investments were Texas (9.2%), Indiana (6.2%) and California (5.7%). the U.K.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedRisk Factors
We may from time to time seek to manage our exposure to interest rate and foreign currency exchange volatility with hedging arrangements, which involve additional risks, including the risks that counterparties may fail to honor their obligations under these arrangements, that these arrangements may not be effective in reducing our exposure to interest rate or currency exchange rate changes, that the amount of income we earn from hedging transactions may be limited by U.S. federal tax provisions governing REITs, and that these arrangements may reduce the benefits to us if interest rates or foreign exchange rates decline.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedRisk Factors
In deciding whether to make an investment in a particular project, we make certain assumptions regarding the expected future performance of the property. property, which assumptions are subject to risks, including, among others, that:
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedMD&A
In October 2025, the Company formed a JV with affiliates of Saber Healthcare Holdings, LLC (“Saber”) to own and lease 64 facilities that were previously wholly owned by affiliates of Saber. The Company issued approximately 5.5 million Omega OP Units with a fair value of $222.4 million in exchange for a 49% equity interest in the JV.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedMD&A
In December 2025, the Company formed two JVs to own and operate, through a RIDEA structure, a CCRC in North Carolina. The Company acquired a 49% equity interest in each of the JVs for aggregate consideration of $42.7 million.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedMD&A
Omega repaid the $50 million term loan (“OP Term Loan”) on April 29, 2025, prior to its original maturity date.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedMD&A
On June 6, 2025, Omega amended its charter to increase the number of authorized shares of Omega common stock from 350.0 million to 700.0 million.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedMD&A
On June 20, 2025, the Company issued $600 million of Senior Notes due 2030 (the “2030 Senior Notes”) that mature on July 1, 2030 and bear interest at a fixed rate of 5.200% per annum, payable semi-annually on January 1 and July 1 of each year, commencing on January 1, 2026. The 2030 Senior Notes were sold at an issue price of 99.118% of their face value, resulting in a discount of $5.3 million. We incurred $5.6 million of deferred costs in connection with the issuance.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedMD&A
On September 30, 2025, the Company entered into a new credit agreement consisting of a new four-year $2.0 billion senior unsecured multicurrency revolving credit facility (the “Revolving Credit Facility”) and a three-year $300.0 million delayed draw term loan facility (the “2028 Term Loan”), replacing our previous $1.45 billion senior unsecured 2021 multicurrency revolving credit facility (the “2021 Revolving Credit Facility”) that was scheduled to mature on October 30, 2025.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedMD&A
On October 15, 2025, the Company redeemed, at par value, the $600.0 million of 5.250% Senior Notes with a scheduled maturity of January 15, 2026.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedMD&A
During the fourth quarter of 2025, we fully repaid the $428.5 million term loan (the “2026 Term Loan”) prior to the August 8, 2026 maturity date. In connection with this repayment, we redesignated nine of the interest rate swaps, with $300 million of notional value, as hedges against our exposure to changes in interest payment cash flows on the 2028 Term Loan. We terminated two of the interest rates swaps with notional value of $128.5 million and paid our swap counterparty $1.7 million.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedMD&A
As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, in the fourth quarter of 2025, we received the final regulatory approvals related to the licensure of the operating assets, and the transition of the equity of Maplewood Senior Living (along with affiliates “Maplewood”) from the Greg Smith estate to Maplewood’s key management team members was completed. Concurrently with the transition of the equity to the Key Principals, on December 11, 2025, Omega entered into a restructuring agreement and amended its master lease agreement for 17 facilities (the “Master Lease”) and its revolving credit facility with Maplewood (the “Maplewood Revolver”). As part of the restructuring agreement and amendments, Omega and Maplewood agreed, among other terms, to (i) reinstate the 2.5% annual contractual rent escalators that were allowed to be deferred as part of the 2023 restructuring agreement terms, resulting in contractual rent of $76.5 million for 2026 for the 17 facilities under the Master Lease, increasing annually by 2.5% thereafter, (ii) allow for the deferral of monthly rent (with 5% interest if outstanding longer than 18 months) if certain conditions are met, but require a minimum amount of contractual rent to be paid annually including $62.1 million for 2026 and $70.0 million for 2027, increasing annually by 2.5% thereafter, (iii) provide up to $43.0 million of incentive payments payable to Maplewood based on achievement of certain metrics and conditions, (iv) extend the maturity date of the Maplewood Revolver from June 2035 to June 2037, (v) retrospectively allow the payment of interest due on the Maplewood Revolver dating back to January 1, 2023 to be paid-in-kind (“PIK”) and (vi) reduce Maplewood’s share of any future potential sales proceeds (in excess of our gross investment) by any incentive payments made to Maplewood. The single facility lease for the Inspir Embassy Row property in Washington D.C. was not modified as part of the restructuring. During 2025, Maplewood paid total contractual rent of $58.9 million compared to the $69.3 million of contractual rent due under the lease agreement for the year after reflecting the impact of deferred escalators. These amounts do not include contractual rent and payments related to Inspir Embassy Row in Washington D.C. of $11.9 million. As Maplewood is on a cash basis of revenue recognition, we have recorded $58.9 million of revenue related to Maplewood for the year ended December 31, 2025 for the contractual rent payments that we received. In addition, prior to the amendment, Maplewood missed cash interest payments of $11.9 million due under the Maplewood Revolver. As the loan is on non-accrual status, the previously missed cash interest payments due under the loan were never recognized as interest income. Therefore, subsequent to the Maplewood Revolver amendment, the missed cash interest payments will increase the principal balance of the loan but will not be included in the amortized cost basis of the loan. As of December 31, 2025, the amortized cost basis of the Maplewood Revolver was $263.6 million, which represents 18.1% of the total amortized cost basis of all of Omega’s real estate loans receivable. See Note 7 – Real Estate Loans Receivable to the Consolidated Financial Statements for more information. In January 2026, Maplewood paid $6.3 million under its lease agreements, $1.1 million of which relates to Inspir Embassy Row in Washington D.C.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedMD&A
As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements to the Consolidated Financial Statements, in July 2025, Genesis Healthcare, Inc. (“Genesis”) commenced voluntary cases under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Northern District of Texas, Dallas Division. Genesis will continue to operate, as a debtor-in-possession (“DIP”), the 31 facilities subject to a master lease agreement with Omega, unless and until Genesis’ leasehold interest under the master lease agreement is rejected or assumed and assigned. We provided $8.0 million of a $30.0 million junior secured DIP financing, along with other lenders, to Genesis to support sufficient liquidity to, among other things, operate its facilities during bankruptcy. As a condition of the DIP financing, Genesis is required to pay Omega full contractual rent under its lease agreement. On January 14, 2026, 101 W State Street Holdings, LLC (“WSSH”) was named the winning bidder in the auction to acquire Genesis’ assets, and on January 26, 2026, the Bankruptcy Court approved the sale to WSSH, subject to satisfaction of the terms and conditions of the purchase and sale agreement between Genesis and WSSH. To the extent that the transaction is consummated, closing is not expected in the next 90-120 days. Genesis has not yet elected to assume and assign the Omega lease to WSSH. If the transaction closes, it is anticipated that the cash proceeds of the sale will be sufficient to repay the DIP and Omega term loans. Please see Note 8 – Non-Real Estate Loans Receivable and Note 20 – Commitments and Contingencies to the Consolidated Financial Statements for additional disclosures regarding the term loans. Since commencing the bankruptcy process in July 2025, Genesis made all required contractual rent and interest payments through the end of 2025. As Genesis is on a cash basis of revenue recognition, we recognized rental income of $51.2 million related to Genesis during the year ended December 31, 2025, which includes $47.0 million for contractual rent payments received and $4.2 million from the application of proceeds from the letter of credit in March 2025 that was held as collateral from Genesis. In addition, we recognized interest income of $17.1 million (which includes $0.1 million from the application of proceeds from the letter of credit) related to loans with Genesis during the year ended December 31, 2025. After the application of proceeds from the letter of credit, there is $3.5 million remaining under the letter of credit. As of December 31, 2025, the remaining two term loans and the DIP loan are on an accrual basis due to the collateral supporting the loans. In January 2026, Genesis paid full contractual rent and interest of $4.5 million.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
AddedMD&A
The increase in miscellaneous income was primarily the result of residual profits received related to an other real estate loan that was paid off during the fourth quarter of 2025.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RemovedMD&A
We continue to monitor these impacts as well as the impacts of other regulatory changes, as discussed in Item 1 – Business – Government Regulation and Reimbursement, including any significant limits on the scope of services eligible for reimbursement and on reimbursement rates and fees, which could have a material adverse effect on an operator’s results of operations and financial condition, which could adversely affect the operator’s ability to meet its obligations to us. As discussed further in “Collectibility Issues” below, in 2024, we have had several operators that have failed to make contractual payments under their lease and loan agreements, and we have agreed to short-term payment deferrals, lease and portfolio restructurings and/or allowed several operators to apply security deposits or letters of credit to pay rent. While we continue to believe that longer term demographics will drive increasing demand for needs-based skilled nursing care, we remain cautious as some of the long-term impacts noted above may continue to have an impact on certain of our operators and their financial conditions.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
During the first quarter of 2024, the remaining nine HUD mortgages with outstanding principal of $41.6 million were paid off. The payoff included a $1.3 million prepayment fee that was recognized as a loss on extinguishment of debt.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
During the first quarter of 2024, we terminated two foreign currency forward contracts that were entered into in March 2021 with notional amounts totaling £70.0 million. Omega received a net cash settlement of $8.4 million as a result of termination. Concurrent with the termination of the two foreign currency forward contracts, also during the first quarter of 2024, we entered into three new foreign currency forward contracts with notional amounts totaling £78.0 million and a GBP-USD forward rate of 1.2707, each of which mature between March 8, 2027 and March 7, 2031. The new currency forward contracts hedge an intercompany loan between a U.S. and U.K. subsidiary.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
As part of the Cindat JV acquisition in July 2024, we assumed a £188.6 million mortgage loan that matures in August 2026 (the “2026 Mortgage Loan”) but can be repaid without a prepayment penalty beginning November 2025. The 2026 Mortgage Loan bears interest at the Sterling Overnight Index Average (“SONIA”) plus an applicable margin of 5.38%. As part of the transaction, we assumed four interest rate cap contracts that ensure the annual interest rate does not exceed 10.38%.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
Throughout 2024, Maplewood Senior Living (along with affiliates, “Maplewood”) continued to short-pay the contractual rent amount due under its lease agreement, paying $47.5 million of contractual rent, a short pay of $21.8 million of the $69.3 million due under its lease agreement. In addition, Maplewood did not pay the $2.7 million of contractual interest due under its secured revolving credit facility (the “Maplewood Revolver”) agreement during 2024. As Maplewood is on a cash basis of revenue recognition, we have recorded $47.5 million of revenue related to Maplewood for the year ended December 31, 2024 for the contractual rent payments that we received. Following the missed interest payments in the first quarter of 2024, we reviewed the characteristics associated with the loan and borrower and adjusted the internal risk rating on the loan, utilized as a component of our allowance for credit loss calculation, from a 4 to a 5 to reflect the increased risk associated with the loan. As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, in May 2024, Omega sent a demand letter to Maplewood notifying it of multiple events of default under its lease, loan and related agreements with Omega, including Mr. Smith’s guaranty, including failure to pay full contractual rent and interest for periods in 2023 and 2024. Omega exercised its contractual rights in connection with these defaults, demanded immediate repayment of past due contractual rent and replenishment of the security deposit and accelerated all principal and accrued interest due under the Maplewood Revolver. On July 31, 2024, we entered into a settlement agreement (the “Settlement Agreement”) with the Greg Smith estate (the “Estate”) and submitted it to the probate court for approval. The Settlement Agreement, among other things, grants Omega the right to direct the assignment of Mr. Smith’s equity to the key members of the existing Maplewood management team (the “Key Principals”), their designee(s) or another designee of Omega’s choosing, with the Estate remaining liable under Mr. Smith’s guaranty until the transition is complete or one year from the court’s approval date, if earlier, and requires Omega to refrain from exercising contractual rights or remedies in connection with the defaults. In the proposed transition, the Key Principals would become the new majority equity holders in the Maplewood entities, which would maintain the Maplewood lease agreement and the Maplewood Revolver provided by Omega. On August 26, 2024, the probate court approved the Settlement Agreement, and in October 2024, following the probate court’s final and non-appealable order approving the Settlement Agreement, we requested and were granted a dismissal without prejudice of our lawsuit against, among others, the Estate. We are still awaiting regulatory approvals related to licensure of the operating assets before the transition will be completed. There is no certainty that the regulatory approvals will be received or that this transition will be completed as intended, on a timely basis, or at all. If the proposed transition plan is not completed, we may incur a substantial loss on the Maplewood Revolver up to the amortized cost basis of the loan. As of December 31, 2024, the amortized cost basis of the Maplewood Revolver was $263.6 million, which represents 17.8% of the total amortized cost basis of all of Omega’s real estate loan receivables. See Note 7 – Real Estate Loans Receivable. In January 2025, Maplewood short-paid the contractual rent and interest amounts due under its lease and loan agreements by $1.5 million.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
Beginning in August 2023, Guardian Healthcare (“Guardian”) did not pay its contractual amounts due under its lease agreement. In April 2024, we transitioned the remaining six facilities previously included in Guardian’s master lease to a new operator for minimum initial contractual rent of $5.5 million per annum with the potential to increase contractual rent dependent on revenue received by the operator. We recorded rental income of $8.3 million related to the lease with the new operator during the year ended December 31, 2024.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
Following Omega and Agemo Holdings, LLC (“Agemo”) entering into a restructuring agreement during the first quarter of 2023, Agemo resumed making contractual rent and interest payments during the second quarter of 2023 and continued to make the required contractual rent and interest payments throughout the remainder of 2023 and 2024. Agemo is on a cash basis of revenue recognition for lease purposes, and we recorded rental income of $23.8 million for the year ended December 31, 2024 for the contractual rent payments that were received. Additionally, as Agemo’s loans are on non-accrual status and are being accounted for under the cost recovery method, the $4.8 million of interest payments that we received during the year ended December 31, 2024 were applied directly against the principal balance outstanding.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
(1) The years ended December 31, 2024, 2023 and 2022 include the application of $2.2 million, $17.6 million and $11.0 million, respectively, of security deposits (letter of credit and cash deposits) in revenue.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
The 2026 Mortgage Loan with £184.6 million or $231.1 million outstanding that bears interest at SONIA plus an applicable margin of 5.38%. We have four interest rate cap contracts that ensure the annual interest rate on the 2026 Mortgage Loan does not exceed 10.38%. The 2026 Mortgage Loan matures in August 2026.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RemovedMD&A
(3) Does not include the impact of Omega providing notification to extend the maturity date of the OP Term Loan to October 30, 2025 in January 2025.
Read it in 10-K Feb 13, 2025 at sec.govopen_in_new
RewordedMD&A
Financing Activities –The change in cash (used in) provided by (used in) financing activities was primarily related to (i) a $899.2 $628.9 million increase decrease in cash proceeds from the issuance of common stock as a result of increased decreased volume under our ATM Program and DRSCPP, partially offset by (i) DRCSPP in 2025, (ii) a $259.6 $97.6 million increase in repayments on other long-term borrowings, net of proceeds, primarily due to repayment of $400 million of 4.95% senior notes in April 2024, (ii) a $92.6 million decrease in proceeds from derivative instruments as a result of various debts during the termination of our forward starting swaps in the second fourth quarter of 2023, 2025, (iii) a $41.6 $94.9 million increase in dividends paid primarily related to share issuances during 2024, 2024 and 2025, (iv) a $3.2 $20.2 million increase in payment of financing related costs related to costs incurred related to the 2025 Omega Credit Agreement entered into in connection with the assumption of the 2026 Mortgage Loan as part of our acquisition of the remaining 51% interest in the Cindat Joint Venture and September 2025, (v) a $2.9 $14.6 million increase in distributions to Omega OP Unit holders. holders and (vi) a $5.6 million increase in redemption of Omega OP Units.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedMD&A
(i) $50 million under the OP Term Loan due April 2025, (ii) $428.5 million under the 2025 Term Loan due August 2025, (iii) $400 million of 4.50% Senior Notes due January 2025 (which were repaid on January 15, 2025 using available cash), (iv) $600 million of 5.25% Senior Notes due January 2026, (v) $700 million of 4.5% Senior Notes due April 2027, (vi) (ii) $550 million of 4.75% Senior Notes due January 2028, (vii) (iii) $500 million of 3.625% Senior Notes due October 2029, (viii) (iv) $600 million of 5.20% Senior Notes due July 2030, (v) $700 million of 3.375% Senior Notes due February 2031, (ix) (vi) $700 million of 3.25% Senior Notes due April 2033 and (x) $231.1 2033, (vii) $300.0 million under the 2026 Mortgage Loan. 2028 Term Loan and (viii) $242.0 million under the Revolving Credit Facility.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedMD&A
The decrease increase in total other income (expense) was primarily due to (i) a $66.5 $54.1 million decrease increase in gain on assets sold resulting from the sale of 21 49 facilities in 2024 2025 compared to the sale of 69 21 facilities in 2023 as we continue to exit certain facilities, operator relationships and/or states to improve the strength of our overall portfolio and 2024, (ii) a $13.5 $43.2 million change increase in other income (expense) – net primarily related to decreased increased interest income on short-term investments due to lower higher invested cash in 2025 compared to the same period in 2024 and gains associated with foreign currency and fair value losses on financial instruments in 2024. 2025 and (iii) a $6.7 million increase in gain on debt extinguishment primarily related to the remaining amortized premium associated with the fair value adjustment.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedMD&A
The increase in interest income was primarily due to a $39.2 $28.3 million increase related to new and refinanced loans and additional fundings to on existing operators loans made throughout 2023 2024 and 2024, 2025, partially offset by (i) a $2.6 $10.3 million decrease related to early principal payments repayments on our loans during 2023 and 2024 and (ii) a $0.8 million net decrease related to loans placed on non-accrual status, primarily the Maplewood Revolver, in which we have recognized less interest income period over period as a result of receiving less cash payments or the loans converting to PIK interest. 2025.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedMD&A
The Our portfolio is made up of (i) 589 561 SNFs, (ii) 290 339 ALFs, (iii) 19 ILFs, (iv) 18 16 specialty facilities, (v) facilities and one MOB, (vi) real estate loans, including CCRC, (ii) fixed rate mortgages on 52 47 SNFs, 43 ALFs, 42 ALFs and two ILFs and (iii) one specialty facility and property adjacent to one ILF and (vii) 12 of our existing facilities that are is held for sale.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedMD&A
Of the $23.8 $22.6 million, $10.9 $6.3 million related to six two facilities that were classified as held for sale for which the carrying value exceeded the fair value less costs to sell, and $12.9 $16.3 million related to eight six held for use facilities (of which $7.2 million relates to four closed facilities) for which the carrying values exceeded the estimated fair value. facilities.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedMD&A
At December 31, 2024, we 2025, our total investments also held other real estate loans (excluding mortgages) receivable of $485.5 million and include non-real estate loans receivable of $332.3 $330.3 million, consisting primarily of secured loans to third-party operators of our facilities, and $88.7 million of investments in 11 unconsolidated joint ventures, which comprise 5 SNFs, one ALF and one specialty facility. facilities.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedMD&A
In addition, our operators have been and continue to be adversely affected by inflation-related cost increases, increases and may be adversely impacted by recently announced global tariffs, each of which may increase expenses, exacerbate labor shortages and increase labor costs, among other impacts, and may be adversely impacted by immigration restrictions and changes to immigration enforcement policy to the extent they contribute to labor shortages. adverse impacts.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedMD&A
During the year ended December 31, 2024, 2025, we placed one existing operator and three new operators, which Omega did not previously have a relationship with prior to 2024, operators on a cash basis of revenue recognition as collection of substantially all contractual lease payments due from them was not deemed probable. recognition.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedMD&A
The overall decrease was partially offset by increases due to (i) the issuance of a $428.5 million term loan the 2030 Senior Notes in June 2025, (ii) the third quarter funding of 2023, (ii) the 2028 Term Loan in November 2026 and (iii) the assumption of the 2026 Mortgage Loan as part of our acquisition of the remaining 51% interest in the Cindat Joint Venture in July 2024 and (iii) increased borrowings on our Revolving Credit Facility during 2024.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedMD&A
In addition, our Our operators have been and continue to be adversely affected by inflation-related cost increases, which may exacerbate labor shortages and increase labor costs, among other impacts, and also may be adversely impacted by immigration restrictions and changes to immigration enforcement policy to the extent they contribute to labor shortages.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new
RewordedMD&A
The 2023 2025 impairments were recognized in connection with two facilities that were classified as held for sale for which the carrying values exceeded the estimated fair value less costs to sell and 23 six held for use facilities for which the carrying value exceeded the fair value. facilities.
Read it in 10-K Feb 9, 2026 at sec.govopen_in_new